News

2nd death reported in Sarepta gene therapy trial for Duchenne muscular dystrophy
Sarepta Therapeutics ( NASDAQ: SRPT) reported a second fatality from acute liver failure in a patient treated with its gene ...
Sarepta Reports Second Death of Patient Using Its Gene Therapy
Sarepta Therapeutics Inc. said a second patient has died of acute liver failure after being treated with its gene therapy for ...
GEN - Genetic Engineering and Biotechnology News3h
Second DMD Patient Dies After Treatment with Sarepta Gene Therapy
Sarepta Therapeutics said it has temporarily suspended shipments of Elevidys® (delandistrogene moxeparvovec-rokl) for infusion in non-ambulatory patients following the second death in three months of ...
Opinion
Lookout Local Santa Cruz14hOpinion
Don’t be confused by RFK Jr.’s federal COVID-19 vaccine policy – protect yourself and your loved ones by getting vaccinated
Health and Human Services Secretary Robert F. Kennedy Jr.'s announcement that the agency will no longer recommend COVID-19 vaccines for healthy children, adults under 65 or pregnant women shocked the ...